Cases 31 - 40 of 1,148
Catalyst Pharmaceuticals, Inc. et al v. Inventia Healthcare Limited
as 1:2023cv01331
Plaintiff:
Catalyst Pharmaceuticals, Inc. and SERB SA
Defendant:
Inventia Healthcare Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Harmony Biosciences, LLC et al v. Lupin Limited et al
as 1:2023cv01286
Plaintiff:
Harmony Biosciences, LLC, Bioprojet Societe Civile de Recherche and Bioprojet Pharma SAS
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc., Novugen Pharma Sdn. Bhd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eli Lilly and Company et al v. MSN Laboratories Private Limited et al
as 1:2023cv01277
Plaintiff:
Eli Lilly and Company, Incyte Corporation and Incyte Holdings Corporation
Defendant:
MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Teva Pharmaceuticals, Inc. et al
as 1:2023cv01268
Plaintiff:
AbbVie Inc.
Defendant:
Teva Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Takeda Pharmaceuticals U.S.A., Inc. v. Scilex Pharmaceuticals Inc. et al
as 1:2023cv01264
Plaintiff:
Takeda Pharmaceuticals U.S.A., Inc.
Defendant:
Scilex Pharmaceuticals Inc. and Scilex Holding Company
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Taro Pharmaceutical Industries Ltd. et al
as 1:2023cv01219
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Orion Corporation et al v. Hetero USA Inc. et al
as 1:2023cv01221
Plaintiff:
Orion Corporation, Bayer Consumer Care AG, Bayer Healthcare LLC and others
Defendant:
Hetero USA Inc., Hetero Labs Ltd., Unit-V and Hetero Labs Ltd.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Novo Nordisk Inc. et al v. Meitheal Pharmaceuticals, Inc. et al
as 1:2023cv01195
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Meitheal Pharmaceuticals, Inc. and Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ZS Pharma, Inc. et al v. Ascent Pharmaceuticals Inc. et al
as 1:2023cv01188
Plaintiff:
ZS Pharma, Inc. and AstraZeneca Pharmaceuticals LP
Defendant:
Ascent Pharmaceuticals Inc. and Hetero Drugs Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Cipla Ltd. et al
as 1:2023cv01196
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Cipla Ltd., Cipla USA Inc. and Invagen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
